While debt from medical school loans is inevitable for most oncology and hematology fellows, there are strategies they can consider to lessen that burden.
Matthew T. Corso
Advertisement
Articles by Matthew T. Corso
It’s no surprise that you acquire significant debt during your medical training. Here are some ways to get those loans paid off.
Both industry and clinical sources agree that cancer vaccine research is finally on the right track to achieve major advances in treatment.
The shortage, which began in 2009, accelerated in 2010, and has shown no signs of abatement so far in 2011, according to Erin R. Fox, PharmD, manager of the Drug Information Service at University of Utah Health Care
Advertisement
Latest Updated Articles
Crisis Averted? Manufacturers Scurry to Meet Demand for DrugsPublished: March 12th 2011 | Updated:
What Oncology and Hematology Fellows Can Do to Reduce Their Loan DebtPublished: December 15th 2011 | Updated:
Emerging Cancer Vaccines Appear to Be on Track for Major AdvancesPublished: June 15th 2011 | Updated:
Loan Repayment Programs for Oncology/Hematology FellowsPublished: October 31st 2011 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma
4
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
5